8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Sep 30, 2024 · 1y ago · Accession 0001171843-24-005393
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Ticker
- BCRX
- CIK
- 882796
- Form type
- 8-K
- Filing date
- Sep 30, 2024
- Report date
- Sep 30, 2024
- Document
- f8k_093024.htm
- Size
- 222 KB